A. Lo

发表

Cost‐effectiveness of the highly effective direct‐acting antivirals in the treatment of chronic hepatitis C in Hong Kong

V. Wong, H. Chan, G. Wong, 2017, Journal of gastroenterology and hepatology.

Association between anthropometric parameters and measurements of liver stiffness by transient elastography.

V. Wong, H. Chan, A. Chan, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

V. Wong, F. Chan, J. Sung, 2011, Gut.

Cost effectiveness of response-guided therapy with peginterferon in the treatment of chronic hepatitis B.

V. Wong, H. Chan, G. Wong, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers.

F. Chan, J. Ching, K. To, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Strategies to manage hepatitis C virus infection disease burden—Volume 4

T. F. Rinke de Wit, V. Wong, C. Hu, 2017, Journal of viral hepatitis.

A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial

V. Wong, G. Wong, R. Kwok, 2018, Liver international : official journal of the International Association for the Study of the Liver.

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4

T. F. Rinke de Wit, V. Wong, C. Hu, 2017, Journal of viral hepatitis.

S. Ng, Justin C.Y. Wu, F. Chan, 2017, Gastroenterology.

Risk of Postpolypectomy Bleeding With Uninterrupted Clopidogrel Therapy in an Industry-Independent, Double-Blind, Randomized Trial.

S. Ng, F. Chan, V. Lee, 2019, Gastroenterology.

Efficacy of tenofovir switch therapy for nucleos(t)ide‐experienced patients with chronic hepatitis B

G. Wong, H. Chan, A. Lo, 2015, Alimentary pharmacology & therapeutics.

Current developments in nucleoside/nucleotide analogues for hepatitis B

G. Wong, A. Lo, 2014, Expert review of gastroenterology & hepatology.

Gastroduodenal Involvement in Asymptomatic Crohn's Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe.

S. Wong, S. Ng, K. Farkas, 2016, Journal of Crohn's & colitis.

Gastrointestinal bleeding

J. Lau, A. Lo, 2014, Endoscopy.

Current developments in nucleoside/nucleotide

G. Wong, A. Lo, 2014 .

Efficacy of Entecavir Switch Therapy in Chronic Hepatitis B Patients with Incomplete Virological Response to Telbivudine

V. Wong, G. Wong, H. Chan, 2013, Antiviral therapy.

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

V. Wong, G. Wong, H. Chan, 2013, Hepatology.

A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients.

V. Wong, H. Chan, A. Lo, 2005, Complementary therapies in medicine.

Serum Hepatitis B Surface Antigen Kinetics in Severe Reactivation of Hepatitis B E Antigen Negative Chronic Hepatitis B Patients Receiving Nucleoside/Nucleotide Analogues

V. Wong, G. Wong, A. Chim, 2013, Antiviral therapy.

Serum interferon‐inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B

G. Wong, A. Chim, H. Chan, 2016, Alimentary pharmacology & therapeutics.

Four-year Outcomes After Cessation of Tenofovir in Immune-tolerant Chronic Hepatitis B Patients

V. Wong, H. Chan, G. Wong, 2017, Journal of clinical gastroenterology.

A Double-Blind, Randomized Trial of Misoprostol for Healing of Small Bowel Bleeding Ulcers in Patients on Continuous Aspirin

S. Ng, Justin C.Y. Wu, F. Chan, 2017 .

Piperacillin/tazobactam Induced Myelosuppression

K. Chow, C. Szeto, N. P. Chan, 2009, Journal of Clinical Medicine Research.

On‐treatment alpha‐fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir

Yee-Kit Tse, V. Wong, G. Wong, 2014, Hepatology.

Historical epidemiology of hepatitis C virus in select countries—volume 4

T. F. Rinke de Wit, V. Wong, O. Tsang, 2017, Journal of viral hepatitis.

Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial

S. Ng, F. Chan, Justin C.Y. Wu, 2017, The Lancet.

Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B.

V. Wong, H. Chan, G. Wong, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

V. Wong, F. Chan, J. Sung, 2011, Gut.

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

V. Wong, G. Wong, H. Chan, 2013, Hepatology.